Abstract
BACKGROUND AND PURPOSE: The PROGRESS trial (Perindopril Protection Against Recurrent Stroke Study) conducted in the early 1990s showed that blood pressure (BP) lowering therapy reduced the risks of recurrent stroke by about 50% after spontaneous intracerebral hemorrhage (ICH). However, the ICH subgroup was a minority, and trial cohorts are invariably selective. Therefore, it is unclear whether the impact of BP control on risk of recurrent stroke in ICH observed in PROGRESS would be as great in real-world practice.
Cite
CITATION STYLE
Lieb, R. (2020). Population-Based Study. In Encyclopedia of Behavioral Medicine (pp. 1707–1707). Springer International Publishing. https://doi.org/10.1007/978-3-030-39903-0_45
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
